SCHEMBL11299511

SCHEMBL11299511

CC(C)(c1ccccc1)N(c1ccc(C(=O)NO)cc1)C1CNC(=O)C1

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ HDAC8 Q9BY41 13/20 0.41
▸ HDAC6 Q9UBN7 9/20 0.41
▸ HDAC1 Q13547 6/20 0.41
▸ HDAC3 O15379 5/20 0.41
▸ HDAC11 Q96DB2 2/20 0.41
▸ HDAC7 Q8WUI4 2/20 0.41
▸ HDAC2 Q92769 2/20 0.41
▸ HDAC4 P56524 1/20 0.41
▸ HDAC10 Q969S8 1/20 0.41
▸ HDAC9 Q9UKV0 1/20 0.41
▸ HDAC5 Q9UQL6 1/20 0.41
▸ CA12 O43570 1/20 0.36
▸ CA1 P00915 1/20 0.36
▸ IDO1 P14902 1/20 0.36
▸ ALOX15 P16050 1/20 0.36
▸ CA9 Q16790 1/20 0.36
▸ HSD17B10 Q99714 1/20 0.36
▸ NCOR2 Q9Y618 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11297190 0.80 HDAC6 (0.44) HDAC8HDAC6HDAC1HDAC3HDAC7
SCHEMBL11301460 0.78 HDAC8 (0.44) HDAC8HDAC6HDAC1HDAC3HDAC11
SCHEMBL11299059 0.76 HDAC6 (0.48) HDAC8HDAC6HDAC1HDAC3HDAC11
SCHEMBL11299528 0.74 HDAC1 (0.40) HDAC8HDAC6HDAC1HDAC3HDAC7
SCHEMBL11301919 0.74 HDAC1 (0.48) HDAC8HDAC6HDAC1HDAC3HDAC11
SCHEMBL11372589 0.74 HDAC1 (0.48) HDAC8HDAC6HDAC1HDAC3HDAC11
SCHEMBL11294960 0.74 HDAC8 (0.41) HDAC8HDAC6HDAC1HDAC3HDAC11
SCHEMBL11299544 0.74 HDAC1 (0.43) HDAC8HDAC6HDAC1HDAC3HDAC11
SCHEMBL11297461 0.72 HDAC8 (0.37) HDAC8HDAC6HDAC1HDAC3HDAC7
SCHEMBL11303497 0.72 HDAC8 (0.46) HDAC8HDAC6HDAC1HDAC2ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2665706-A1 NOVEL 4-AMINO-N-HYDROXY-BENZAMIDES AS HDAC INHIBITORS FOR THE TREATMENT OF CANCER F.HOFFMANN-LA ROCHE AG (CH) 2013-11-27 — — EP claimed
WO-2012098132-A1 NOVEL 4-AMINO-N-HYDROXY-BENZAMIDES AS HDAC INHIBITORS FOR THE TREATMENT OF CANCER F. HOFFMANN-LA ROCHE AG (CH) 2012-07-26 — — WO claimed
EP-2665706-A1 NOVEL 4-AMINO-N-HYDROXY-BENZAMIDES AS HDAC INHIBITORS FOR THE TREATMENT OF CANCER F.HOFFMANN-LA ROCHE AG (CH) 2013-11-27 — — EP disclosed
WO-2012098132-A1 NOVEL 4-AMINO-N-HYDROXY-BENZAMIDES AS HDAC INHIBITORS FOR THE TREATMENT OF CANCER F. HOFFMANN-LA ROCHE AG (CH) 2012-07-26 — — WO disclosed
Send feedback